NCT03002259 - Dexamethasone for Cardiac Surgery-II Trial | Biotech Hunter

Enrollment

1,956

Participants

Timeline

Start Date

September 1, 2018

Primary Completion Date

January 31, 2023

Study Completion Date

January 31, 2023

Conditions

Inflammatory Response

Interventions

DRUG

Dexamethasone

Dexamethasone administered as a single IV injection after induction of anaesthesia, but before initiation of CPB. Prepare as a 20 mg/mL dexamethasone solution, made up with 0.9% saline to 10 ml.

Trial Locations (1)

3004

Alfred Health, Melbourne